4.6 Article

Pregnancy and non-pregnancy related ovarian vein thrombosis: Clinical course and outcome

期刊

THROMBOSIS RESEARCH
卷 146, 期 -, 页码 84-88

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.thromres.2016.09.001

关键词

Anticoagulation; Ovarian vein thrombosis; Pregnancy; Post-partum; Thrombophilia

向作者/读者索取更多资源

Objective: To collect and summarize demographic, clinical, laboratory and radiologic characteristics, as well as management and follow-up data, of patients diagnosed with ovarian vein thrombosis. Methods: A multicenter retrospective review of all patients diagnosed with ovarian vein thrombosis between January 2000 and May 2015 al three university hospitals. Results: Data of 74 women were analyzed. Mean age was 31 +/- 9 years. Sixty (81.1%) cases were pregnancy related. The presence of at least one underlying Fisk factor (most commonly active infection or surgery) was more common among pregnancy than non-pregnancy related cases (61,7 vs. 14.3%, P = 0.002). Anticoagulation therapy was administered in 98.6% of patients and adjunctive antibiotic therapy in 39 (52.7%). At a median follow-up of 40 +/- 38 months, only one recurrent thrombotic event was observed, and no events of death. Median duration of anticoagulation treatment tended to be longer among patients with non-pregnancy related OVT (6 months [3-14] vs. 3 months [3-6], P = 0.1). Thrombophilic evaluation detected any thrombophilic risk factor in 12 (20%) and 6 (42.9%) women with pregnancy and non-pregnancy related ovarian vein thrombosis, respectively (P = 0.09). Conclusion: Pregnancy-related ovarian vein thrombosis is characterized by a provoked nature and a high rate of resolution after short term treatment. Treatment of three months duration of anticoagulation following this condition appeared in this study to be safe, with no recurrences encountered during a median follow up of 40 months. Thrombophilia seems to have an important role in ovarian vein thrombosis and should be evaluated in non-pregnancy related cases. (C) 2016 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Obstetrics & Gynecology

Is real-time dynamic cervical shortening predictive of preterm birth?- A case control study

Amihai Rottenstreich, Neta Gochman, Geffen Kleinstern, Gabriel Levin, Yishay Sompolinsky, Misgav Rottenstreich, Hen Y. Sela, Simcha Yagel, Shay Porat

Summary: This retrospective study found that dynamic cervical shortening is associated with an increased risk of preterm birth, especially when the minimal cervical length is measured. The rates of spontaneous preterm birth were significantly higher in those with dynamic cervix compared to the control group matched for maximal cervical length, and similar to the control group matched for minimal cervical length. The value of cervical length as a negative predictor of preterm birth is limited in the setting of dynamic cervical change.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2022)

Article Oncology

Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans

Geffen Kleinstern, J. Brice Weinberg, Sameer A. Parikh, Esteban Braggio, Sara J. Achenbach, Dennis P. Robinson, Aaron D. Norman, Kari G. Rabe, Nicholas J. Boddicker, Celine M. Vachon, Connie E. Lesnick, Timothy G. Call, Danielle M. Brander, Laura Z. Rassenti, Thomas J. Kipps, Janet E. Olson, James R. Cerhan, Neil E. Kay, Richard R. Furman, Curtis A. Hanson, Tait D. Shanafelt, Susan L. Slager

Summary: This study found significant associations between 41 CLL susceptibility variants and CLL-PRS with MBL risk, while little evidence of any association between MBL risk and environmental factors was observed. The CLL-PRS showed significant associations with EA-CLL risk and AA-CLL risk, indicating the need for further research in this population.

LEUKEMIA (2022)

Article Obstetrics & Gynecology

Trial of labor after cesarean in primiparous women with fetal macrosomia

Naama Lessans, Stav Martonovits, Misgav Rottenstreich, Simcha Yagel, Geffen Kleinstern, Hen Y. Sela, Shay Porat, Gabriel Levin, Joshua Rosenbloom, Yosef Ezra, Amihai Rottenstreich

Summary: Spontaneous labor onset, epidural anesthesia, and prior cesarean delivery due to non-arrest disorders are independently associated with higher vaginal birth after cesarean rate among women delivering a macrosomic fetus, with overall favorable success rate in the presence of these factors.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2022)

Article Obstetrics & Gynecology

Duration of the second stage of labour and risk of subsequent spontaneous preterm birth

Geffen Kleinstern, Roy Zigron, Shay Porat, Joshua Rosenbloom, Misgav Rottenstreich, Yishay Sompolinsky, Amihai Rottenstreich

Summary: The duration of the second stage of labor in a first term vaginal delivery is not associated with subsequent spontaneous preterm birth (sPTB). However, there is an increased risk of sPTB following a second-stage cesarean section, especially if performed after a prolonged second stage.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)

Article Oncology

Vaccination History and Risk of Lymphoma and Its Major Subtypes

Geffen Kleinstern, Melissa C. Larson, Stephen M. Ansell, Carrie A. Thompson, Grzegorz S. Nowakowski, Timothy G. Call, Dennis P. Robinson, Matthew J. Maurer, Raphael Mwangi, Andrew L. Feldman, Neil E. Kay, Anne J. Novak, Thomas M. Habermann, Susan L. Slager, James R. Cerhan

Summary: This study investigated the association between vaccinations and the risk of different lymphoma subtypes. The results showed that vaccinations against influenza and yellow fever were inversely associated with lymphoma risk. However, the association between hepatitis B vaccination and lymphoma risk was complex. These findings suggest that the vaccination-related lymphoma risk may vary depending on the time since vaccination and the type of vaccine.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Article Immunology

The Effect of Gestational Age at BNT162b2 mRNA Vaccination on Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Levels

Amihai Rottenstreich, Gila Zarbiv, Esther Oiknine-Djian, Olesya Vorontsov, Roy Zigron, Geffen Kleinstern, Dana G. Wolf, Shay Porat

Summary: Maternal antibody levels and transplacental antibody transfer vary based on the gestational age at the time of SARS-CoV-2 vaccination, with lowest levels observed in those vaccinated in the first trimester. A third booster dose may enhance antibody levels and could be beneficial for those who completed the 2-dose vaccine series early in pregnancy.

CLINICAL INFECTIOUS DISEASES (2022)

Article Infectious Diseases

Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study

Amihai Rottenstreich, Gila Zarbiv, Esther Oiknine-Djian, Olesya Vorontsov, Roy Zigron, Geffen Kleinstern, Dana G. Wolf, Shay Porat

Summary: This study aimed to evaluate the impact of maternal vaccination against SARS-CoV-2 in early versus late third trimester on transplacental transfer and neonatal levels of antibodies. The results showed that early vaccination in pregnancy enhanced transplacental antibody transfer and increased neonatal neutralizing antibody levels, indicating that early vaccination in the third trimester may enhance neonatal immune protection.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Letter Oncology

Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis

Nicholas J. Boddicker, Sara J. Achenbach, Sameer A. Parikh, Geffen Kleinstern, Esteban Braggio, Aaron D. Norman, Kari G. Rabe, Celine M. Vachon, Connie E. Lesnick, Timothy G. Call, Janet E. Olson, James R. Cerhan, Neil E. Kay, Curtis A. Hanson, Tait D. Shanafelt, Susan L. Slager

LEUKEMIA (2022)

Article Immunology

Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Neutralization After Antenatal Messenger RNA Vaccination

Amihai Rottenstreich, Olesya Vorontsov, Or Alfi, Gila Zarbiv, Esther Oiknine-Djian, Roy Zigron, Geffen Kleinstern, Michal Mandelboim, Shay Porat, Dana G. Wolf

Summary: Neutralization efficiency against SARS-CoV-2 Omicron variant was evaluated in maternal and cord blood sera after antenatal BNT162b2 vaccination. The study found that neutralizing antibodies against Omicron were not present at the time of delivery after two doses of vaccination. Thus, a third booster dose was necessary to build neutralizing antibody capacity against Omicron in mothers and neonates.

CLINICAL INFECTIOUS DISEASES (2022)

Article Oncology

Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota

Geffen Kleinstern, Dirk R. Larson, Cristine Allmer, Aaron D. Norman, Grace Muntifering, Jason Sinnwell, Alissa Visram, Vincent Rajkumar, Angela Dispenzieri, Robert A. Kyle, Susan L. Slager, Shaji Kumar, Celine M. Vachon

Summary: High body mass index is a prognostic factor for the progression of MGUS, and this association may be stronger among females.

BLOOD CANCER JOURNAL (2022)

Article Hematology

Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening method

Celine M. Vachon, Josiah Murray, Cristine Allmer, Dirk Larson, Aaron D. Norman, Jason P. Sinnwell, Angela Dispenzieri, Geffen Kleinstern, Alissa Visram, Robert A. Kyle, S. Vincent Rajkumar, Susan L. Slager, Shaji K. Kumar, David L. Murray

Summary: Mass-spectrometry (MS) assays can detect monoclonal gammopathy of undetermined significance (MGUS) at an earlier stage, and the prevalence of heavy chain MGUS is higher in African Americans and first-degree relatives of patients with hematologic disorders. The MALDI-TOF assay can identify more cases of MGUS compared to conventional gel-based methods, but the relative differences based on race, family history, and age are similar to prior studies.

BLOOD ADVANCES (2022)

Article Hematology

Progression and survival of MBL: a screening study of 10 139 individuals

Susan L. Slager, Sameer A. Parikh, Sara J. Achenbach, Aaron D. Norman, Kari G. Rabe, Nicholas J. Boddicker, Janet E. Olson, Geffen Kleinstern, Connie E. Lesnick, Timothy G. Call, James R. Cerhan, Celine M. Vachon, Neil E. Kay, Esteban Braggio, Curtis A. Hanson, Tait D. Shanafelt

Summary: Monoclonal B-cell lymphocytosis (MBL) is a common hematological premalignant condition that is associated with a fourfold increased risk of lymphoid malignancies in individuals with low-count MBL (LC-MBL).
Article Immunology

Kinetics of Maternally Derived Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in Infants in Relation to the Timing of Antenatal Vaccination

Amihai Rottenstreich, Gila Zarbiv, Esther Oiknine-Djian, Olesya Vorontsov, Roy Zigron, Geffen Kleinstern, Shay Porat, Dana G. Wolf

Summary: This study investigated the durability of maternally-derived anti-SARS-CoV-2 antibodies in infants following antenatal BNT162b2 vaccination. The results showed that maternal vaccination led to efficient transplacental transfer of antibodies, with persistent anti-SARS-CoV-2 antibodies detected at 3 months of age in all infants. Furthermore, the timing of antenatal immunization had an impact on the kinetics and concentration of maternally-derived antibodies.

CLINICAL INFECTIOUS DISEASES (2023)

Article Oncology

Physical activity and the risk of non-Hodgkin lymphoma subtypes: A pooled analysis

Terry Boyle, Geffen Kleinstern, Paige M. Bracci, James R. Cerhan, Yolanda Benavente, Delphine Casabonne, Brian C-H Chiu, Thomas M. Habermann, Elizabeth A. Holly, Mark Liebow, Aaron Norman, Ora Paltiel, Dennis Robinson, Nathaniel Rothman, Rania Abu Seir, Susan L. Slager, Paul J. Villeneuve, Sophia S. Wang, Dennis D. Weisenburger, John J. Spinelli

Summary: This study, which pooled data from nine case-control studies, found that moderate-to-vigorous intensity physical activity can reduce the risk of non-Hodgkin lymphoma.

INTERNATIONAL JOURNAL OF CANCER (2023)

Correction Oncology

Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes (vol 36, pg 2835, 2023)

Sonja I. Berndt, Joseph Vijai, Yolanda Benavente, Nicola J. Camp, Alexandra Nieters, Zhaoming Wang, Karin E. Smedby, Geffen Kleinstern, Henrik Hjalgrim, Caroline Besson, Christine F. Skibola, Lindsay M. Morton, Angela R. Brooks-Wilson, Lauren R. Teras, Charles Breeze, Joshua Arias, Hans-Olov Adami, Demetrius Albanes, Kenneth C. Anderson, Stephen M. Ansell, Bryan Bassig, Nikolaus Becker, Parveen Bhatti, Brenda M. Birmann, Paolo Boffetta, Paige M. Bracci, Paul Brennan, Elizabeth E. Brown, Laurie Burdett, Lisa A. Cannon-Albright, Ellen T. Chang, Brian C. H. Chiu, Charles C. Chung, Jacqueline Clavel, Pierluigi Cocco, Graham Colditz, Lucia Conde, David V. Conti, David G. Cox, Karen Curtin, Delphine Casabonne, Immaculata De Vivo, Arjan Diepstra, W. Ryan Diver, Ahmet Dogan, Christopher K. Edlund, Lenka Foretova, Joseph F. Fraumeni, Attilio Gabbas, Herve Ghesquieres, Graham G. Giles, Sally Glaser, Martha Glenn, Bengt Glimelius, Jian Gu, Thomas M. Habermann, Christopher A. Haiman, Corinne Haioun, Jonathan N. Hofmann, Theodore R. Holford, Elizabeth A. Holly, Amy Hutchinson, Aalin Izhar, Rebecca D. Jackson, Ruth F. Jarrett, Rudolph Kaaks, Eleanor Kane, Laurence N. Kolonel, Yinfei Kong, Peter Kraft, Anne Kricker, Annette Lake, Qing Lan, Charles Lawrence, Dalin Li, Mark Liebow, Brian K. Link, Corrado Magnani, Marc Maynadie, James McKay, Mads Melbye, Lucia Miligi, Roger L. Milne, Thierry J. Molina, Alain Monnereau, Rebecca Montalvan, Kari E. North, Anne J. Novak, Kenan Onel, Mark P. Purdue, Kristin A. Rand, Elio Riboli, Jacques Riby, Eve Roman, Gilles Salles, Douglas W. Sborov, Richard K. Severson, Tait D. Shanafelt, Martyn T. Smith, Alexandra Smith, Kevin W. Song, Lei Song, Melissa C. Southey, John J. Spinelli, Anthony Staines, Deborah Stephens, Heather J. Sutherland, Kaitlyn Tkachuk, Carrie A. Thompson, Herve Tilly, Lesley F. Tinker, Ruth C. Travis, Jenny Turner, Celine M. Vachon, Claire M. Vajdic, Anke Van den Berg, David J. Van den Berg, Roel C. H. Vermeulen, Paolo Vineis, Sophia S. Wang, Elisabete Weiderpass, George J. Weiner, Stephanie Weinstein, Nicole Wong Doo, Yuanqing Ye, Meredith Yeager, Kai Yu, Anne Zeleniuch-Jacquotte, Yawei Zhang, Tongzhang Zheng, Elad Ziv, Joshua Sampson, Nilanjan Chatterjee, Kenneth Offit, Wendy Cozen, Xifeng Wu, James R. Cerhan, Stephen J. Chanock, Susan L. Slager, Nathaniel Rothman

LEUKEMIA (2023)

Article Hematology

Adhesive properties of plasma-circulating and platelet-derived microvesicles from healthy individuals

E. O. Artemenko, S. I. Obydennyi, K. S. Troyanova, G. A. Novichkova, D. Y. Nechipurenko, M. A. Panteleev

Summary: In this study, we investigated the adhesive properties of circulating plasma-derived and platelet-derived microvesicles (MVs) and their potential role in thrombus growth. The results showed that both types of MVs weakly bound fibrinogen but did not stably adhere to immobilized fibrinogen. Moreover, the presence of these MVs did not significantly affect thrombus formation. Therefore, MVs present in the plasma of healthy individuals are unlikely to directly contribute to thrombus formation under arterial flow conditions.

THROMBOSIS RESEARCH (2024)

Letter Hematology

Recent monthly mortality for pulmonary embolism in the US

Giuseppe Lippi, Camilla Mattiuzzi, Emmanuel J. Favaloro

THROMBOSIS RESEARCH (2024)

Article Hematology

Exploration of rotational thromboelastometry (ROTEM) to characterize the coagulation profiles of newly diagnosed pediatric leukemia patients

Marium Malik, Maha Al-Ghafry, Abraham Haimed, Julia Su, Maribel Lema, Linda Shore-Lessersson, Suchitra S. Acharya

Summary: This study analyzed and evaluated leukemia-associated coagulopathy in newly diagnosed pediatric leukemia patients using CCTs and ROTEM. The results showed that fibrinogen and platelets played a significant role in causing coagulopathies in this population. This suggests the utility of using CCTs and ROTEM in the pediatric population to evaluate hemostatic function and guide blood product replacement.

THROMBOSIS RESEARCH (2024)

Review Hematology

Thrombotic triad in microgravity

Mohammad M. Elahi, Alexandra N. Witt, Edward L. G. Pryzdial, Paul B. McBeth

Summary: Thrombotic disease may be underdiagnosed in microgravity conditions, and the underlying factors are still poorly understood. A case of internal jugular vein thrombosis was recently diagnosed in a low-risk female astronaut, and six out of ten additional crew members showed risk factors for jugular venous flow. Observations in space and studies on Earth suggest that microgravity affects blood flow, coagulation, and vascular function.

THROMBOSIS RESEARCH (2024)

Review Hematology

Comparison of important factors to patients recovering from pulmonary embolism and items covered in patient-reported outcome measures: A mixed-methods systematic review

Stian Ingemann-Molden, Christina Krogner Caspersen, Nanna Rolving, Anette Arbjerg Hojen, Frederikus A. Klok, Erik L. Grove, Barbara Cristina Brocki, Jane Andreasen

Summary: This study found that no single PROM covered all aspects considered important by PE patients. PROMs recommended in the ICHOM core set covered most aspects, but worrisome thoughts, hypervigilance around symptoms, and uncertainty of illness were not covered.

THROMBOSIS RESEARCH (2024)

Article Hematology

Driver gene KRAS aggravates cancer-associated stroke outcomes

Haomin Yan, Tsutomu Sasaki, Yasufumi Gon, Kumiko Nishiyama, Hideaki Kanki, Hideki Mochizuki

Summary: The incidence of cancer-associated stroke has increased with the prolonged survival times of cancer patients. In this study, the researchers focused on the driver gene KRAS and found that KRAS mutations exacerbated neurological deficits after stroke and promoted tumor growth. They also identified the upregulation of pro-inflammatory responses and the promotion of STAT3 phosphorylation in mice with KRAS mutations. Additionally, the researchers found that colorectal cancer patients with stroke onset within 3 months after cancer diagnosis had a worse prognosis.

THROMBOSIS RESEARCH (2024)

Letter Hematology

Identification of two de novo variants causing inherited antithrombin deficiency by quantitative analysis of variant alleles

Tomoki Togashi, Satomi Nagaya, Makiko Meguro-Horike, Haruto Matsumoto, Yuta Imai, Koichi Yamaguchi, Yoshinari Fujii, Haruka Moriya, Yuika Kikuchi, Ibuki Yasuda, Shin-ichi Horike, Eriko Morishita

THROMBOSIS RESEARCH (2024)

Article Hematology

Shock score for prediction of clinical outcomes among stable patients with acute symptomatic pulmonary embolism

Marta Najarro, Winnifer Briceno, Carmen Rodriguez, Alfonso Muriel, Sara Gonzalez, Ana Castillo, Ignacio Jara, Parth Rali, Catalin Toma, Behnood Bikdeli, David Jimenez

Summary: The CPES score is a useful tool in identifying the risk of hemodynamic deterioration in normotensive patients with acute PE, with acceptable C-statistic, excellent specificity, and low positive predictive value.

THROMBOSIS RESEARCH (2024)

Article Hematology

Trimethylamine-N-oxide (TMAO) and basic fibroblast growth factor (bFGF) are possibly involved in corticosteroid resistance in adult patients with immune thrombocytopenia

Lei Liu, Huifang Xu, Jian Wang, Haiyan Wang, Saisai Ren, Qian Huang, Mingyan Zhang, Hui Zhou, Chunyan Yang, Lu Jia, Yu Huang, Hao Zhang, Yanling Tao, Ying Li, Yanan Min

Summary: This study investigated the gut microbiota metabolites and cytokines, chemokines, and growth factors in patients with ITP and found their association with treatment responsiveness. The findings suggest that imbalanced secretion of cyto(chemo)kins/growth factors and inadequate levels of TMAO are characteristic of patients with ITP.

THROMBOSIS RESEARCH (2024)

Article Hematology

Safety of fixed-dose heparin titration boluses in underweight patients

Roxanne Mcknight, Mohammad Salameh, Lee Ann Jones, Greta Anton, Lindsay Carter

Summary: This study evaluated the safety of fixed-dose heparin titration boluses in underweight patients with VTE. The results showed that although underweight patients required more frequent holding of heparin, there was no significant increase in bleeding risk.

THROMBOSIS RESEARCH (2024)